Institutional shares held 38.6 Million
30.9K calls
44.3K puts
Total value of holdings $337M
$270K calls
$387K puts
Market Cap $352M
39,107,800 Shares Out.
Institutional ownership 98.59%
# of Institutions 165


Latest Institutional Activity in ANGO

Top Purchases

Q2 2025
Assenagon Asset Management S.A. Shares Held: 313K ($2.81M)
Q2 2025
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Shares Held: 16.7K ($151K)
Q2 2025
Gamma Investing LLC Shares Held: 1.7K ($15.3K)
Q2 2025
Versant Capital Management, Inc Shares Held: 58 ($521)
Q2 2025
Fifth Third Bancorp Shares Held: 49 ($441)

Top Sells

Q2 2025
Gsa Capital Partners LLP Shares Held: 22.4K ($201K)
Q2 2025
Massmutual Trust CO Fsb Shares Held: 279 ($2.51K)
Q2 2025
Farther Finance Advisors, LLC Shares Held: 120 ($1.08K)
Q1 2025
Millennium Management LLC Shares Held: 1.24M ($11.1M)
Q1 2025
Citadel Advisors LLC Shares Held: 203K ($1.82M)

About ANGO

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.


Insider Transactions at ANGO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
611K Shares
From 16 Insiders
Grant, award, or other acquisition 589K shares
Open market or private purchase 22.6K shares
Sell / Disposition
7.13K Shares
From 2 Insiders
Open market or private sale 4.06K shares
Payment of exercise price or tax liability 3.07K shares

Track Institutional and Insider Activities on ANGO

Follow ANGIODYNAMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGO shares.

Notify only if

Insider Trading

Get notified when an Angiodynamics Inc insider buys or sells ANGO shares.

Notify only if

News

Receive news related to ANGIODYNAMICS INC

Track Activities on ANGO